Bridgewest Group
Dr. Laurence Cooper is Executive Chairman for BIO4T2. As a c-level executive, scientist, physician, entrepreneur, and educator, Laurence has been innovating and leading teams to solve complex and noteworthy problems in cancer, gene therapy and immunotherapy.
His passion for discovering new knowledge and creating life-saving therapies is at the heart of his endeavors. With deep expertise, a pioneering spirit and a caring demeaner, Laurence has had a tremendous impact on others, from research lab to corporate boardroom, to patient bedside.
Currently, Laurence is on the board of Directors for Secure Transfusion Services and CellChorus. Laurence has an MD in Medicine and a PhD in Immunology from Case Western Reserve University.
This person is not in any teams
This person is not in any offices
Bridgewest Group
Inspiring solutions for a better tomorrow drive the success of their group. They have established ourselves as an innovative private investor by placing people at the forefront.